PSCHInvesco S&P SmallCap Health...


$ 41.86 $ -0.18 (-0.43 %)    

Friday, 05-Jul-2024 09:41:23 EDT
QQQ $ 495.57 $ 3.83 (0.78 %)
DIA $ 393.26 $ 0.62 (0.16 %)
SPY $ 553.97 $ 2.18 (0.4 %)
TLT $ 92.56 $ 0.47 (0.52 %)
GLD $ 220.96 $ 1.45 (0.66 %)
$ 42.04
$ 41.86
$ 0.00 x 0
$ 41.96 x 100
$ 41.86 - $ 41.86
$ 34.62 - $ 45.18
8,582
na
na
$ 0.99
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-health-care-company-fortrea-stock-diving-today

Fortrea reported weak Q1 FY24 results and lowered its revenue outlook. Backlog at $7.4B, adjusted EBITDA declined, and EPS missed.

 organon-beats-on-q1-womens-health-leads-the-charge

Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.